Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Glass Ceiling Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Intellectual Property
Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.
Sign up for a 7-day FREE trial today!
Latest News in Intellectual Property
-
November 25, 2021
Apple Wins 3rd Contest In War Over 3G, 4G Patents
The High Court ruled on Thursday that a patent owned by three subsidiaries of the PanOptis group for technology used in 3G and 4G wireless devices is obvious and uninventive and therefore invalid, handing Apple a win in its protracted legal battle with the units.
-
November 24, 2021
Fed. Circ. Tells TTAB To Review Pawn Shop's TMs
The Federal Circuit on Wednesday overturned the Trademark Trial and Appeal Board's refusal to cancel two trademark registrations for the word "Money Mart" in a dispute between two businesses using the same name.
-
November 24, 2021
Fed. Circ. Affirms PTAB Ax Of Indivior's Suboxone Patent
A split Federal Circuit panel on Wednesday affirmed a Patent Trial and Appeal Board decision invalidating most claims of an Indivior patent on its opioid addiction treatment Suboxone, finding that the patent could not be traced back to an earlier application.
-
November 24, 2021
As ANDA Suit Venue Options Shrink, Del., NJ Rule For Now
One year after the Federal Circuit limited venue options for patent suits over generic drugs, a new ruling has clamped down further. But so far, most cases are still being filed in Delaware and New Jersey, the traditional hot spots for pharmaceutical litigation.
-
November 24, 2021
GOP Lawmakers Urge Tai To Oppose COVID Vaccine IP Waiver
In a letter Wednesday spelling out their priorities for the World Trade Organization's upcoming summit, Republican leaders on congressional trade committees urged U.S. Trade Representative Katherine Tai to stand against a waiver of intellectual property protections on COVID-19 vaccines.
Areas of Coverage
- LITIGATION
- Infringement suits over patents, copyrights, and trademarks
- Patent Trial and Appeal Board disputes
- Abbreviated New Drug Application (ANDA) litigation
- Section 301 cases
- Trade secrets disputes
- Licensing and royalty fights
- Right-of-publicity suits
- Antitrust disputes involving IP issues
- AGENCIES
- U.S. Patent and Trademark Office
- U.S. Copyright Office
- U.S. International Trade Commission
- World Intellectual Property Organization
- POLICY & REGULATION
- Patent reform legislation and related bills in Congress
- Efforts to streamline international intellectual property law
- ENFORCEMENT
- Piracy and counterfeiting actions
- International trade disputes involving IP issues
- PROFILES
- Personnel moves
- Profiles of IP practices
Readership
- Intellectual property lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the life sciences, technology, and other IP-focused industries
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals